10-year Outcome of a Randomized Trial Comparing Neoadjuvant Chemoradiotherapy and Surgery with Surgery Alone for Esophageal Cancer (CROSS trial)

Cross Study, Ate van der Gaast(Erasmus MC), Ernst Jan Spillenaar Bilgen(Radboud University Nijmegen), Geke A.P. Hospers(University Medical Center Groningen), Mark I. van Berge Henegouwen(University of Namur), Jannet C. Beukema(University Medical Center Groningen), Geert-Jan Creemers, Tom Rozema(Radboud University Nijmegen), R.J.B. Blaisse(Rijnstate Hospital), Joël Shapiro(The Netherlands Cancer Institute), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Olivier R. Busch(Amsterdam Neuroscience), Cornelis J.A. Punt(Utrecht University), Johannes J. Bonenkamp, Miguel A. Cuesta(Hospital General Universitario de Albacete), Pieter van Hagen(Erasmus MC), Janny G. Reinders(Dutch Art Institute), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Ben M. Eyck(Erasmus MC Cancer Institute), John Th. M. Plukker(University Medical Center Groningen), Maarten C.C.M. Hulshof(Academic Medical Center), Henk M.W. Verheul(Erasmus MC Cancer Institute), Ewout W. Steyerberg(Erasmus MC), Anna H.M. Piet(Amsterdam University Medical Centers), Bas P. L. Wijnhoven(Inserm), Hugo W. Tilanus(Amsterdam UMC Location University of Amsterdam), Caroline M. van Rij(Erasmus MC), Berend J. van der Wilk(Erasmus MC Cancer Institute), Fiebo J.W. ten Kate, Maurice J.C. van der Sangen(Radboud University Nijmegen)

Unknown

February 1, 2021

Cited by 0

|Epidemiology|2009|4.9k

|BMJ|2020|3.2k

|Journal of Clinical Epidemiology|2001|2.6k

|European Heart Journal|2014|1.9k

|New England Journal of Medicine|2002|1.6k

Related Papers